X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5384) 5384
Publication (362) 362
Newsletter (241) 241
Book Review (48) 48
Magazine Article (20) 20
Newspaper Article (13) 13
Book Chapter (5) 5
Dissertation (3) 3
Trade Publication Article (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pravastatin (4236) 4236
humans (4163) 4163
male (3178) 3178
female (2645) 2645
middle aged (2288) 2288
aged (1720) 1720
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (1530) 1530
cholesterol (1516) 1516
statins (1505) 1505
index medicus (1485) 1485
pravastatin - therapeutic use (1337) 1337
adult (1321) 1321
cardiac & cardiovascular systems (1284) 1284
simvastatin (1269) 1269
cholesterol, ldl - blood (1164) 1164
pharmacology & pharmacy (1116) 1116
atorvastatin (1090) 1090
anticholesteremic agents - therapeutic use (1020) 1020
prevention (999) 999
risk factors (984) 984
cholesterol - blood (927) 927
hypercholesterolemia (904) 904
hypercholesterolemia - drug therapy (904) 904
animals (879) 879
treatment outcome (861) 861
atherosclerosis (842) 842
coronary-heart-disease (742) 742
risk (742) 742
peripheral vascular disease (714) 714
pravastatin - pharmacology (662) 662
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (637) 637
myocardial-infarction (634) 634
events (631) 631
medicine, general & internal (600) 600
men (593) 593
atorvastatin calcium (541) 541
triglycerides - blood (535) 535
double-blind method (531) 531
lipids - blood (514) 514
hypercholesterolemia - blood (506) 506
cholesterol, hdl - blood (504) 504
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (496) 496
lovastatin (496) 496
lipids (491) 491
heptanoic acids - therapeutic use (487) 487
mortality (483) 483
therapy (468) 468
pyrroles - therapeutic use (448) 448
drug therapy (440) 440
antilipemic agents (436) 436
pravastatin - administration & dosage (436) 436
disease (434) 434
prospective studies (430) 430
coronary heart disease (425) 425
simvastatin - therapeutic use (416) 416
research (410) 410
follow-up studies (404) 404
time factors (404) 404
c-reactive protein (389) 389
cardiovascular disease (384) 384
analysis (378) 378
inflammation (378) 378
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (375) 375
coronary disease - prevention & control (370) 370
rats (364) 364
statin (352) 352
dose-response relationship, drug (350) 350
hyperlipidemias - drug therapy (350) 350
aged, 80 and over (349) 349
heart-disease (339) 339
hypolipidemic agents - therapeutic use (339) 339
cardiovascular-disease (335) 335
efficacy (329) 329
cardiovascular agents (328) 328
low density lipoproteins (328) 328
rosuvastatin (328) 328
care and treatment (322) 322
coa reductase inhibitors (317) 317
cardiovascular diseases - prevention & control (315) 315
randomized controlled trials as topic (315) 315
anticholesteremic agents - pharmacology (309) 309
hypertension (304) 304
drug therapy, combination (297) 297
anticholesteremic agents - administration & dosage (293) 293
safety (289) 289
primary prevention (285) 285
fluvastatin (277) 277
cardiovascular diseases (270) 270
coronary disease - blood (270) 270
cardiovascular (266) 266
coronary heart-disease (266) 266
health aspects (263) 263
rosuvastatin calcium (261) 261
hypercholesterolemia - complications (260) 260
endocrinology & metabolism (259) 259
biomarkers - blood (248) 248
mice (247) 247
density-lipoprotein cholesterol (242) 242
diabetes (242) 242
lipoproteins (239) 239
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5461) 5461
German (49) 49
Spanish (35) 35
Japanese (26) 26
Russian (24) 24
Chinese (17) 17
French (17) 17
Italian (13) 13
Portuguese (11) 11
Czech (4) 4
Polish (3) 3
Swedish (3) 3
Serbian (2) 2
Danish (1) 1
Hungarian (1) 1
Norwegian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Vascular Surgery, ISSN 0741-5214, 2005, Volume 41, Issue 4, pp. 733 - 733
BACKGROUND: Statins lower the levels of low-density lipoprotein (LDL) cholesterol and C-reactive protein (CRP). Whether this latter property affects clinical... 
MEDICINE, GENERAL & INTERNAL | DENSITY-LIPOPROTEIN CHOLESTEROL | INFLAMMATION | CARDIOVASCULAR-DISEASE | MARKERS | RISK | ACUTE CORONARY SYNDROMES | PRAVASTATIN | PRIMARY PREVENTION | PREDICTION | ATORVASTATIN | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Myocardial Infarction - blood | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Male | Secondary Prevention | Coronary Disease - mortality | Incidence | C-Reactive Protein - metabolism | Pyrroles - administration & dosage | Heptanoic Acids - administration & dosage | Cholesterol, LDL - blood | Female | C-Reactive Protein - drug effects | Pyrroles - therapeutic use | Pravastatin - therapeutic use | Heptanoic Acids - pharmacology | Pravastatin - pharmacology | Coronary Disease - blood | Risk Factors | Proportional Hazards Models | Cholesterol, LDL - drug effects | Fluoroquinolones - therapeutic use | Biomarkers - blood | Atorvastatin Calcium | Coronary Disease - prevention & control | Pyrroles - pharmacology | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Myocardial Infarction - drug therapy | Pravastatin - administration & dosage | Anticholesteremic Agents - administration & dosage | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Myocardial Infarction - prevention & control | Anticholesteremic Agents - pharmacology | Cardiovascular disease | Heart attacks | Cholesterol | Statins
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9738, pp. 333 - 339
Summary Background HDL-cholesterol concentrations are inversely associated with occurrence of cardiovascular events. We addressed, using the JUPITER trial... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | ATHEROSCLEROSIS | PREVENTION | RANDOMIZED-TRIAL | TORCETRAPIB | TRIGLYCERIDES | PRAVASTATIN | HYPERCHOLESTEROLEMIA | CORONARY-HEART-DISEASE | A-I | HIGH-DENSITY-LIPOPROTEIN | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Myocardial Infarction - blood | Humans | Middle Aged | Male | Fluorobenzenes - administration & dosage | Angioplasty - statistics & numerical data | Incidence | C-Reactive Protein - metabolism | Adult | Cholesterol, LDL - blood | Female | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Pyrimidines - administration & dosage | Risk Factors | Rosuvastatin Calcium | Cholesterol, LDL - drug effects | Treatment Outcome | Biomarkers - blood | Stroke - blood | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Primary Prevention - methods | Angina, Unstable - prevention & control | Cholesterol, HDL - blood | Aged | Myocardial Infarction - prevention & control | Fluorobenzenes - therapeutic use | Sulfonamides - administration & dosage | Angina, Unstable - etiology | Complications and side effects | Hypercholesterolemia | Dosage and administration | Research | Cardiovascular diseases | Drug therapy | Risk factors | Statins | Fees & charges | Studies | Women | Heart attacks | Data collection | Cardiovascular disease | Apolipoproteins | Cholesterol
Journal Article
Circulation, ISSN 0009-7322, 2017, Volume 136, Issue 20, pp. 1878 - +
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Medical Science Monitor, ISSN 1234-1010, 06/2018, Volume 24, pp. 3903 - 3908
Background: Dyslipidemia is the most frequent comorbidity in patients with cardiovascular disease. However, studies examining the relationship between blood... 
Cholesterol, LDL | Atrial Fibrillation | Triglycerides | MEDICINE, RESEARCH & EXPERIMENTAL | FOLLOW-UP | RISK | APOLIPOPROTEINS | RECEPTOR | LEFT-VENTRICULAR HYPERTROPHY | DENSITY-LIPOPROTEIN CHOLESTEROL | PARADOX | DISEASE | MODULATE | PRAVASTATIN
Journal Article